Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Commentary: Let the Time Fly: Dopamine is the Arbiter
Volume: 17 Issue: 1
Author(s): Xiaodong Liu, Changzheng Zhang, Oscar Arias-Carrion* Ti-Fei Yuan*
Affiliation:
- Trastornos del Movimiento y Sueno, Hospital General Dr. Manuel Gea Gonzalez, Ciudad de Mexico,Mexico
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai,China
Export Options
About this article
Cite this article as:
Liu Xiaodong, Zhang Changzheng, Arias-Carrion Oscar *, Yuan Ti-Fei *, Commentary: Let the Time Fly: Dopamine is the Arbiter, CNS & Neurological Disorders - Drug Targets 2018; 17 (1) . https://dx.doi.org/10.2174/1871527316999170505110106
DOI https://dx.doi.org/10.2174/1871527316999170505110106 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cover Image Description for CAR 13-4
Current Alzheimer Research Do we Need a New Procedure for the Assessment of Adverse Events in Anti-migraine Clinical Trials?
Recent Patents on CNS Drug Discovery (Discontinued) Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies
Current Neuropharmacology miR-135a Suppresses Calcification in Senescent VSMCs by Regulating KLF4/STAT3 Pathway
Current Vascular Pharmacology Current Understanding of the Interplay Between Catechol-OMethyltransferase Genetic Variants, Sleep, Brain Development and Cognitive Performance in Schizophrenia
CNS & Neurological Disorders - Drug Targets Structural Characteristics of Short Peptides in Solution
Protein & Peptide Letters Meet Our Editorial Board Member
Current Aging Science Patent Selections
Recent Patents on Biomarkers Non-Neuronal Cell Modulation Relieves Neuropathic Pain: Efficacy of the Endogenous Lipid Palmitoylethanolamide
CNS & Neurological Disorders - Drug Targets Palmitoylethanolamide Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice
CNS & Neurological Disorders - Drug Targets Measurement of Palmitoylethanolamide and Other N-Acylethanolamines During Physiological and Pathological Conditions
CNS & Neurological Disorders - Drug Targets Comparative Pharmacokinetics and Metabolism Studies in Lean and Diet- Induced Obese Mice: An Animal Efficacy Model for 11β -Hydroxysteroid Dehydrogenase Type 1 (11β -HSD1) Inhibitors
Drug Metabolism Letters Advances in the Treatment of Autoimmune Diseases; Cellular Activity, Type-1/Type-2 Cytokine Secretion Patterns and their Modulation by Therapeutic Peptides
Current Medicinal Chemistry Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke
Current Pharmaceutical Design The Migraine-Ischemic Stroke Connection: Potential Pathogenic Mechanisms
Current Molecular Medicine Editorial [Hot Topic:New Approaches for the Treatment of Pain and Inflammation (Guest Editor: Kaustav Biswas)]
Current Topics in Medicinal Chemistry Effect of Diet on Tissue Levels of Palmitoylethanolamide
CNS & Neurological Disorders - Drug Targets The Effects of Cognitive Speed of Processing Training Among Older Adults with Psychometrically- Defined Mild Cognitive Impairment
Current Alzheimer Research 2-Acetylbenzofurans: Synthesis, Reactions and Applications
Current Organic Chemistry Update on Tandem Pore (2P) Domain K+ Channels
Current Drug Targets